Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study
- PMID: 8319181
- DOI: 10.1002/1097-0142(19930715)72:2<511::aid-cncr2820720230>3.0.co;2-q
Expression and prognostic significance of estrogen and progesterone receptors in adenocarcinoma of the uterine cervix. An immunocytochemical study
Abstract
Background: Adenocarcinoma of the uterine cervix typically is an aggressive neoplasm with a propensity for early invasion and dissemination. Little data are available correlating histologic, histochemical, or immunocytochemical parameters with the biologic behavior of this neoplasm. Specifically, the implication of expression of estrogen and progesterone receptors in cervical adenocarcinoma is essentially undefined.
Methods: An immunocytochemical hormone receptor assay using specific monoclonal antibodies against estrogen receptors (ER) and progesterone receptors (PgR) was used to study paraffin-embedded specimens from 54 patients with primary cervical adenocarcinomas. The specimens were evaluated for heterogeneity and intensity of staining. An attempt also was made to study the relationship between the pattern of hormone receptor expression and other established prognostic indicators.
Results: In all patients, diffuse positive staining of benign endocervical epithelial or stromal cells was observed. Positive immunostaining was seen in the adenocarcinoma specimens of 16 of 54 (30%) patients for ER and 19 of 54 (35%) patients for PgR. Expression of ER and PgR statistically correlated with each other (P = 0.0001). Endocervical-type adenocarcinoma had the highest degree of staining for both ER and PgR. Clear cell carcinomas and intestinal-type carcinomas were negative for both receptors. Positivity for ER and PgR inversely correlated with histologic grade as defined by the International Federation of Gynecology and Obstetrics (FIGO). The relationship between hormone receptor expression and FIGO stage was not statistically significant. Survival was associated with clinical stage (P = 0.004) and with immunocytochemical status of ER expression (P = 0.032) and PgR expression (P = 0.009).
Conclusions: This study of 54 specimens from patients with cervical adenocarcinoma suggests that positive expression of ER and PgR is associated with prolonged survival.
Similar articles
-
Adenocarcinoma of the cervix. Expression and clinical significance of estrogen and progesterone receptors.Cancer. 1997 Feb 1;79(3):505-12. Cancer. 1997. PMID: 9028361
-
Progesterone receptor is a favorable prognostic factor of radiation therapy for adenocarcinoma of the uterine cervix.Int J Radiat Oncol Biol Phys. 2000 Jul 15;47(5):1229-34. doi: 10.1016/s0360-3016(00)00495-8. Int J Radiat Oncol Biol Phys. 2000. PMID: 10889376
-
Immunocytochemical localization of estrogen and progesterone receptor and prognosis in human primary breast cancer.Cancer Res. 1990 Nov 1;50(21):7057-61. Cancer Res. 1990. PMID: 2208173
-
Association between Silva pattern-based classification and endocervical adenocarcinoma: a systematic review and meta-analysis.Int J Gynecol Cancer. 2024 Nov 4;34(11):1704-1710. doi: 10.1136/ijgc-2024-005639. Int J Gynecol Cancer. 2024. PMID: 39277184 Free PMC article.
-
Pattern based classification of endocervical adenocarcinoma: a review.Pathology. 2018 Feb;50(2):134-140. doi: 10.1016/j.pathol.2017.09.011. Epub 2017 Dec 11. Pathology. 2018. PMID: 29241973 Free PMC article. Review.
Cited by
-
The pathogenesis, diagnosis, and management of metastatic tumors to the ovary: a comprehensive review.Clin Exp Metastasis. 2017 Jun;34(5):295-307. doi: 10.1007/s10585-017-9856-8. Epub 2017 Jul 20. Clin Exp Metastasis. 2017. PMID: 28730323 Free PMC article. Review.
-
Expression of Estrogen and Progesterone Receptor in Tumor Stroma Predicts Favorable Prognosis of Cervical Squamous Cell Carcinoma.Int J Gynecol Cancer. 2017 Jul;27(6):1247-1255. doi: 10.1097/IGC.0000000000001004. Int J Gynecol Cancer. 2017. PMID: 28472813 Free PMC article.
-
Elevated expression of G protein-coupled receptor 30 (GPR30) is associated with poor prognosis in patients with uterine cervical adenocarcinoma.Histol Histopathol. 2020 Apr;35(4):351-359. doi: 10.14670/HH-18-157. Epub 2019 Sep 4. Histol Histopathol. 2020. PMID: 31483053
-
Differentiating rectal carcinoma by an immunohistological analysis of carcinomas of pelvic organs based on the NCBI Literature Survey and the Human Protein Atlas database.Surg Today. 2012 Jun;42(6):515-25. doi: 10.1007/s00595-012-0167-z. Epub 2012 Mar 23. Surg Today. 2012. PMID: 22441574 Review.
-
Diagnostic Algorithmic Proposal Based on Comprehensive Immunohistochemical Evaluation of 297 Invasive Endocervical Adenocarcinomas.Am J Surg Pathol. 2018 Aug;42(8):989-1000. doi: 10.1097/PAS.0000000000001090. Am J Surg Pathol. 2018. PMID: 29851704 Free PMC article.